0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

for treating in the prodromal phase?

Session 4: Is there evidence…

Koen Paemeleire

Prof., MD, PhD, Department of Neurology, Ghent University Hospital Ghent, Belgium

Download presentation

Previous

TTH or CM or both? Multiple diagnosis

Next

for using triptan during the aura phase?

You Might Also Like

Related Embedded Video Item Thumbnail for neuroinflammation in migraine?
Related Embedded Video Item Thumbnail TTH or CM or both? Multiple diagnosis
Related Embedded Video Item Thumbnail Anti-CGRP therapies: similar but not the same
Related Embedded Video Item Thumbnail Do we need drug holidays? Con
Related Embedded Video Item Thumbnail When to evaluate effectiveness?- Anti-CGRPs and gepants

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128